I. Vinograd, R. Baslo, N. Eliakim-Raz, L. Farbman, A. Taha, A

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Vaccines for the elderly
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Benchmarking inappropriate empirical antibiotic treatment
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz 
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children  N. Agrinier, M. Le Maréchal,
R. Cantón  Clinical Microbiology and Infection 
H-H. Lin, K-L. Hsu, W. W-C. Ko, Y-C. Yang, Y-W. Chang, M-C. Yu, K-T
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?  M. Paul, N. Zemer-Wassercug, O.
J. Cairo, R. Hachem, G. Rangaraj, B. Granwehr, I. Raad 
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
Surveillance of Legionnaires’ disease in Austria
Do clinicians consider the results of the BinaxNOW Streptococcus pneumoniae urinary antigen test when adapting antibiotic regimens for pneumonia patients? 
Vector control: a cornerstone in the malaria elimination campaign
The role of vaccination in preventing pneumococcal disease in adults
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
P. Carrillo-Santisteve, P.L. Lopalco 
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes  S. Ladhani,
Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective.
Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit  E. Theocharidou, B. Agarwal, G. Jeffrey,
The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study  E. Manea, J. Sojo-Dorado, R.E. Jipa, S.N.
Levofloxacin in the treatment of ventilator-associated pneumonia
Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study  M.R. Berndsen,
Metagenomics and probiotics
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
F. Blasi, P. Palange, G. Rohde, T. Severin, G. Cornaglia, R. Finch 
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Benchmarking inappropriate empirical antibiotic treatment
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.
Current experience in treating invasive zygomycosis with posaconazole
Vaccinations against respiratory tract infections at Hajj
Reducing antibiotic use in influenza: challenges and rewards
Vaccines for the elderly
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study  O. Zusman,
Are we losing the fight against malaria one more time?
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Factors associated with influenza vaccination among adult cancer patients: a case– control study  I. Vinograd, R. Baslo, N. Eliakim-Raz, L. Farbman, A. Taha, A. Sakhnini, A. Lador, S.M. Stemmer, A. Gafter-Gvili, D. Fraser, L. Leibovici, M. Paul  Clinical Microbiology and Infection  Volume 20, Issue 9, Pages 899-905 (September 2014) DOI: 10.1111/1469-0691.12625 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Patients’ flow chart and reasons for exclusion from the preliminary cohort. Clinical Microbiology and Infection 2014 20, 899-905DOI: (10.1111/1469-0691.12625) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.